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Abstract
The phenotypic equilibrium, i.e. heterogeneous population of cancer cells tend-
ing to a fixed equilibrium of phenotypic proportions, has received much attention in
cancer biology very recently. In previous literature, some theoretical models were
used to predict the experimental phenomena of the phenotypic equilibrium, which
were often explained by different concepts of stabilities of the models. Here we
present a stochastic multi-phenotype branching model by integrating conventional
cellular hierarchy with phenotypic plasticity mechanisms of cancer cells. Based on
our model, it is shown that: (i) our model can serve as a framework to unify the
previous models for the phenotypic equilibrium, and then harmonizes the different
kinds of average-level stabilities proposed in these models; and (ii) path-wise conver-
gence of our model provides a deeper understanding to the phenotypic equilibrium
from stochastic point of view. That is, the emergence of the phenotypic equilibrium
is rooted in the stochastic nature of (almost) every sample path, the average-level
stability just follows from it by averaging stochastic samples.
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Figure 1: The phenotypic equilibrium of cancer cells. The figure is generated from the
data (SW620 colon cancer cell line) in [7]. In this experiment, two cellular phenotypes
were identified: cancer stem cells (CSCs) and non-stem cancer cells (NSCCs). It is shown
that no matter where the initial state is (as four different cases shown in the figure), the
CSCs proportion will converge to a fixed proportion as time passes. The same is true for
NSCCs proportion. This phenomenon is termed phenotypic equilibrium [6].
1 Introduction
Stability is ubiquitous in biology, ranging from physicochemical homeostasis in cellular
microenvironments to ecological constancy and resilience [1, 2, 3]. It is noteworthy that
not only can the stability phenomenon arise in normal living systems, but it can also hap-
pen in abnormal organisms such as cancer. As a large family of diseases with abnormal
cell growth, cancer is generally acknowledged to be the malignant progression along with
a series of stability-breaking changes (e.g. genomic instability) within the normal organ-
isms [4]. However, some recent researches reveal the other side of cancer. An interesting
phenotypic equilibrium was reported in some cancers [5, 6, 7]. That is, the population
composed of different cancer cells will tend to a fixed equilibrium of phenotypic propor-
tions over time regardless of initial states (Fig. 1). These findings provided new insights
to the research of cancer heterogeneity.
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The experimental works also stimulate theoreticians to put forward reasonable models
for interpreting the phenotypic equilibrium [6, 8, 9, 10, 11, 12, 13, 14]. In particular, it
was reported that the intrinsic interconversion between different cellular phenotypes, also
called phenotypic plasticity [15, 16], could play a crucial role in stabilizing the mixture of
phenotypic proportions in cancer. As a pioneering work, Gupta et al proposed a discrete-
time Markov chain model to describe the phenotypic transitions in breast cancer cell lines
[6]. In their model, three phenotypes were identified: stem-like cells (S), basal cells (B)
and luminal cells (L). The phenotypic transitions among them can be captured by the
transition probability matrix as follows:
P =
 1− PS→B − PS→L PS→B PS→LPB→S 1− PB→S − PB→L PB→L
PL→S PL→B 1− PL→S − PL→B
 , (1)
where Pi→j represents the probability of the transition from phenotype i to j. Accord-
ing to the limiting theory of discrete-time finite-state Markov chain, there exists unique
equilibrium distribution ~pi = (piS, piB, piL) such that ~pi = ~piP , provided P is irreducible
and aperiodic [17]. The Markov chain will converge to ~pi regardless of where it begins.
By fitting the Markov chain model to their experimental data, the equilibrium propor-
tions of stem-like, basal and luminal cells were predicted by the equilibrium distribution
piS, piB, piL respectively.
Even though the Markov chain model fitted the experimental results in breast cancer
cell lines very well, Zapperi and La Porta [8] questioned the validity of the phenotypic
transitions and gave an alternative explanation to the phenotypic equilibrium, which was
based on the conventional cancer stem cell (CSC) model with imperfect CSC biomarkers.
Moreover, Liu et al showed that the negative feedback mechanisms of non-linear growth
kinetics of cancer cells can also control the balance between different cellular phenotypes
[18]. These works suggested that the phenotypic plasticity may not be the only explana-
tion to the phenotypic equilibrium. To further reveal the mechanisms giving rise to the
phenotypic equilibrium, it is more convincing to study the models integrating the phe-
notypic plasticity with the other conventional cellular processes of cancer. Motivated by
this, a series of works discussed the phenotypic equilibrium by establishing the models
coordinating with both hierarchical cancer stem cell paradigm and phenotypic plasticity
[9, 10, 11, 12, 13, 14]. In these works, the phenotypic equilibria were intimately related
to the stable steady-state behavior of the corresponding ordinary differential equations
(ODEs) models. In other words, if one can model the dynamics of the phenotypic propor-
tions as the following system of ODEs
d~x
dt
= ~F (~x),
the unique stable fixed point ~x∗ (if exists) corresponds to the equilibrium proportions.
3
The aforementioned works have showed that the phenotypic equilibrium can be ex-
plained by different concepts of stabilities in different models. Thus a natural question
is whether there exists a unified framework to harmonize the equilibrium distribution of
the Markov chain model and the stable steady-state behavior of the ODEs model. In this
study, we try to address this issue by establishing a multi-phenotype branching (MPB)
model [19]. On one hand, our model integrates the phenotypic plasticity with the cellular
processes (such as cell divisions) that have extensively been studied in cancer biology. On
the other hand, the model is stochastic and closer to the reality with finite population size
[20, 21]. Based on this model, it is shown that the ODEs model can be derived by taking
the expectation of our model. More specifically, the ODEs model is just the proportion
equation of the MPB model. Besides, the Markov chain model is also shown to be closely
related to our model. That is, the Kolmogorov forward equation of the continuous-time
Markov chain model is a special case of the proportion equation provided that the divi-
sion rates of stem-like, basal and luminal cells are the same. Interestingly, “same doubling
time” of the three phenotypes was just observed in Gupta et al’s experiment when they
used the Markov chain model to explain the phenotypic equilibrium [6], which is in line
with our theoretical prediction. Moreover, our result also shows that one should be more
cautious about the application of the Markov chain in modeling cell-state dynamics in
larger time scales, since the Markov chain model takes no account of different capabili-
ties of divisions by cancer stem cells and non-stem cancer cells.
More importantly, by showing almost sure convergence of the MPB model, the sta-
tionarity of the Markov chain model and the stability of the ODEs model can be unified as
the average-level stability of our model. Note that the almost sure convergence indicates
the path-wise stability of stochastic samples, providing a more profound explanation to
the phenotypic equilibrium. In other words, the phenotypic equilibrium is actually rooted
in the stochastic nature of (almost) every path sample; the average-level stability just fol-
lows from it by averaging all the stochastic samples. Furthermore, it is also shown that,
not only can the model with phenotypic plasticity give rise to the path-wise convergence,
but the conventional cancer stem cell model without phenotypic plasticity can also lead
to the convergence under certain conditions. This echoes the works [8, 18] that the phe-
notypic plasticity is not the only explanation to the phenotypic equilibrium.
The paper is organized as follows. The model is presented in Section 2. Main results
are shown in Section 3. Conclusions are in Section 4.
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2 Model
2.1 Assumptions
In this section we give the assumptions of our model. Consider a population composed
of different cancer cell phenotypes. For pure theoretical investigations, the number of the
phenotypes can be any n in general [13, 22]. However, to better illustrate our theoretical
results on the basis of more concrete biological background, enlightened by [6], we here
focus on the specific model consisting of three phenotypes: stem-like cells (S), basal cells
(B) and luminal cells (L). The main assumptions are listed as follow:
1. Stem-like cells can perform three types of divisions: symmetric division, symmet-
ric differentiation and asymmetric division [23, 24, 25]. That is, a stem-like cell can
divide into two identical stem-like cells (symmetric division) or two identical differenti-
ated cancer cells (symmetric differentiation; it can also divide into a stem-like cell and a
differentiated cancer cell (asymmetric division).
• symmetric division: S αSP1−→ S+S;
• symmetric differentiation: S αSP2−→ B+B or S αSP3−→ L+L;
• asymmetric division: S αSP4−→ S+B or S αSP5−→ S+L.
αS is the division rate (or termed synthesis rate [18]), with the meaning that a stem-like
cell will wait an exponential time with expectation αS and then perform one particular
type of division with probability Pi (note that
∑5
i=1 Pi = 1). Suppose the waiting time
and the division strategy are independent to each other, then the product of αS and Pi
governs the reaction rate of the corresponding division type.
2. For non-stem cancer cells, i.e. basal or luminal cells, we assume that not only can they
undergo symmetric divisions with limited times, but they can also perform phenotypic
conversions. To illustrate this, let us take B phenotype as an example. Suppose a newly-
born B cell can divide at most m times. If we denote Bi as the B cell that has already
divided i times, then we have the following hierarchical structure:
• B0 αB−→ B1+B1;
• ...
• Bm−1 αB−→ Bm+Bm;
• Bm αBm−→ ∅.
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αB is the division rate, and αBm is the death rate of Bm. Moreover, assume that a B cell
can convert into an S cell (termed de-differentiation [26]) by phenotypic plasticity. Let
the dedifferentiation rate of Bi be βBi , then we have
• B0
βB0−→ S;
• ...
• Bm βBm−→ S.
For simplicity, it is often assumed that βB0 = ... = βBm [12], denoted as βB for short.
Meanwhile, note that a B cell can also convert into an L cell [6]. Since the biological
mechanisms of the phenotypic conversions between different non-stem cancer cells are
still poorly understood, for simplicity it is assumed that the phenotypic transitions be-
tween B and L can only happen in the same hierarchical level. That is, supposing that a
newly-born L cell can also divide at mostm times, Li is the L cell that has already divided
i times, then we have
• Bi γB−→ Li;
γB is the transition rate. In fact, this assumption implies B −→ L with constant rate γB
overall, which is in line with the assumption in [6]. For luminal cells, similarly, their
cellular processes are shown as follows:
• Li αL−→ Li+1+Li+1 (0 ≤ i ≤ m− 1);
• Lm αLm−→ ∅.
• Li βL−→ S (0 ≤ i ≤ m);
• Li γL−→ Bi (0 ≤ i ≤ m).
2.2 Multi-phenotypic branching (MPB) model
Based on the cellular processes listed in the last subsection, we can model this cellu-
lar system as a continuous-time Markov process in the discrete state space of cell num-
bers (Chapter 11 in [27]). If we let X1 be the cell number of S phenotype, ~X2 =
(X
(0)
2 , X
(1)
2 , ..., X
(m)
2 )
T be the vector representing the cell numbers of Bi cells, and ~X3 =
(X
(0)
3 , X
(1)
3 , ..., X
(m)
3 )
T be the vector representing the cell numbers of Li cells, then the
dynamics of ~X = (X1, ~X2, ~X3)T can be modeled as a multi-phenotype branching process
[19]. If we define Pr(~x; t) be the probability of ~X = ~x at time t, according to the theory of
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Chemical Master Equation (CME), the rate of change of Pr(~x; t) is equal to the transitions
into ~x minus the transitions out of it, i.e.
dPr(~x; t)
dt
=
∑
~x′ 6=~x
T~x′→~xPr(~x′; t)−
∑
~x′ 6=~x
T~x→~x′Pr(~x; t), (2)
where T~x′→~x is the transition rate from ~x′ to ~x and T~x→~x′ is the transition rate from ~x to ~x′
(see A for more details).
In next section we will show that the ODEs model and the Markov chain model can be
derived from our model. For convenience we term our multi-phenotype branching model
the MPB model.
3 Results
3.1 Deterministic equations derived from the MPB model
To relate our MPB model to the ODEs model, we consider the mean dynamics of the
MPB model by averaging all the stochastic samples of it.
Let 〈 ~X〉 be the expectation of ~X , that is, for each component we define
〈Xi〉 :=
∑
~x
xiPr(~x; t).
We multiply xi on the both sides of Eq. (2), and then calculate the summation over all ~x
∑
~x
xi
dPr(~x; t)
dt
=
∑
~x
xi
∑
~x′ 6=~x
T~x′→~xPr(~x′; t)−
∑
~x′ 6=~x
T~x→~x′Pr(~x; t)
 .
For S cells:
d〈X1〉
dt
= αS (P1 − P2 − P3) 〈X1〉+ βB
m∑
i=0
X
(i)
2 + βL
m∑
i=0
X
(i)
3 . (3)
For B cells:
d〈X(0)2 〉
dt
= αS (2P2 + P4) 〈X1〉 − (αB + βB + γB) 〈X(0)2 〉+ γLX(0)3 ;
d〈X(i)2 〉
dt
= 2αB〈X(i−1)2 〉 − (αB + βB + γB) 〈X(i)2 〉+ γLX(i)3 (1 ≤ i ≤ m− 1);
d〈X(m)2 〉
dt
= 2αB〈X(m−1)2 〉 − (αBm + βB + γB) 〈X(m)2 〉+ γLX(m)3 .
(4)
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For L cells:
d〈X(0)3 〉
dt
= αS (2P3 + P5) 〈X1〉 − (αL + βL + γL) 〈X(0)3 〉+ γBX(0)2 ;
d〈X(i)3 〉
dt
= 2αL〈X(i−1)2 〉 − (αL + βL + γL) 〈X(i)3 〉+ γBX(i)2 (1 ≤ i ≤ m− 1);
d〈X(m)3 〉
dt
= 2αL〈X(m−1)2 〉 − (αLm + βL + γL) 〈X(m)3 〉+ γBX(m)2 .
(5)
Then it is not difficult to see that the dynamics of 〈 ~X〉 can be captured by a system of
linear ODEs,
d〈 ~X〉
dt
= G〈 ~X〉, (6)
where
G = [gij](2m+3)×(2m+3) =
(
αS(P1−P2−P3) βB ··· βB βL ··· βL
αS(2P2+P4) −(αB+βB+γB) 0 ··· γL ··· 0
0 2αB −(αB+βB+γB) 0 ··· ··· 0··· ··· ··· ··· ··· ··· ···
)
. (7)
Furthermore, it should be noted that, Eq. (6) describes the cell number dynamics
of each phenotype at each hierarchical level. If we denote X2 =
∑m
i=0X
(i)
2 and X3 =∑m
i=0X
(i)
3 as the total cell numbers of B and L phenotypes respectively, then it is often
the dynamics of ~X∗ = (X1, X2, X3)T that interests people. That is,
d〈X1〉
dt = αS (P1 − P2 − P3) 〈X1〉+ βB〈X2〉+ βL〈X3〉;
d〈X2〉
dt = αS (2P2 + P4) 〈X1〉+ (αB − βB − γB)〈X2〉+ γL〈X3〉 − (αB + αBm)〈X
(m)
2 〉;
d〈X3〉
dt = αS (2P3 + P5) 〈X1〉+ γB〈X2〉+ (αL − βL − γL)〈X3〉 − (αL + αLm)〈X
(m)
3 〉.
(8)
We can see that Eq. (8) is not linear of 〈 ~X∗〉, which also depends on 〈X(m)2 〉 and 〈X(m)3 〉
separately. Technically this is due to the limited capability of divisions of B and L pheno-
types. In the limit of m, or when m is relatively large in comparison to observational time
scales (e.g. t / m), Eq. (8) can approximately be expressed as a linear system of 〈 ~X∗〉:
d〈 ~X∗〉
dt
≈ G∗〈 ~X∗〉, (9)
where
G∗ = [g∗ij]3×3 =
(
αS(P1−P2−P3) βB βL
αS(2P2+P4) αB−βB−γB γL
αS(2P3+P5) γB αL−βL−γL
)
. (10)
In this way the model reduces to the three-phenotypic model investigated in [11]. How-
ever, Eq. (8) should be adopted for describing larger time scales (e.g. t  m). Note that
it is inconvenient to analyze Eq. (8) directly, we will show later that analyzing Eq. (6) is
quite helpful for the understanding of Eq. (8), especially in the study of the phenotypic
equilibrium.
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3.2 Proportion equation: Bridging the MPB model and the ODEs
model
Since Eq. (6) describes the dynamics of the absolute numbers of different cellular phe-
notypes, we term it the number equation. However, to investigate the phenotypic equilib-
rium, we are more concerned about the dynamics of the relative numbers (i.e. proportions)
of different cellular phenotypes. Let ~p be the vector representing the proportions of dif-
ferent cellular phenotypes. By replacing 〈 ~X〉 in Eq. (6) with ~p , we have the equation
governing the phenotypic proportions as follows (see B)
d~p
dt
= G~p− ~peTG~p, (11)
where e = (1, ..., 1)T . We term Eq. (11) the proportion equation. It is noteworthy that the
stable steady-state behavior of Eq. (11) just corresponds to the phenotypic equilibrium
investigated in [12, 13]. The proportion equation thus connects the MPB model and the
ODEs model in previous literature, implying that the ODEs model can be seen as the
average-level counterpart of the stochastic MPB model. To show the stability of Eq. (11),
we have the following theorem (see C for the proof):
Theorem 1. There exists unique positive stable fixed point ~µ in Eq. (11) provided that G
is irreducible 1.
Theorem 1 shows that the deterministic population dynamics of cancer cells will tend
to an equilibrium mixture of phenotypic proportions as time passes. Besides, let ~p∗ be the
proportion vector of ~X∗, i.e.
~p∗ = (p∗1, p
∗
2, p
∗
3) = (p1,
m∑
i=0
p
(i)
2 ,
m∑
i=0
p
(i)
3 ).
Given limt→∞ ~p = ~µ (Theorem 1),
lim
t→∞
~p∗ = lim
t→∞
(p1,
m∑
i=0
p
(i)
2 ,
m∑
i=0
p
(i)
3 ) = (µ1,
m∑
i=0
µ
(i)
2 ,
m∑
i=0
µ
(i)
3 ) = ~µ
∗.
Thus we have the following result for ~p∗:
Corollary 1. Under the same condition in Theorem 1, ~p∗ will tend to a fixed positive
vector ~µ∗ as t→∞.
1Strictly speaking, for completing the theorem it is necessary to add a small perturbation to the initial
state in rare cases, see C
9
Corollary 1 indicates the phenotypic equilibrium of the three-phenotypic model in Eq.
(8). Moreover, it should be pointed out that, the results in Theorem 1 and Corollary 1 can
be seen as the average-level stabilities following from the the path-wise convergence of
the MPB model, which will be discussed in Sec. 3.4.
3.3 TheMarkov chainmodel as a special case of the proportion equa-
tion
Note that the Markov chain model Eq. (1) is discrete-time and the MPB model is continuous-
time; to compare the two models in the same time scale, we turn our attention from
discrete-time Markov chain to continuous-time Markov chain. Consider the standard
model of continuous-time Markov chain. That is, let Pi(t) be the probability of the
Markov chain being in state i at time t, its dynamics can be captured by the Kolmogorov
forward equation:
d~P (t)
dt
= QT ~P (t), (12)
where Q-matrix [qij]3×3 satisfying
qij ≥ 0 ∀i 6= j, (13)
qii = −
∑
j:j 6=i
qij. (14)
We now discuss the relation between ~P (t) and ~p∗. By replacing 〈 ~X∗〉 in Eq. (9) with
~p∗, we obtain the proportion equation governing ~p∗ 2
d~p∗
dt
= G∗~p∗ − ~p∗eTG∗~p∗, (15)
where e = (1, 1, 1)T and G∗ in Eq. (10). If we let the sum of each column of G∗ is the
same, i.e.
αS = αB = αL = κ,
then Eq. (15) becomes
d~p∗
dt
= (G∗ − κI)~p∗, (16)
2The derivation of Eq. (15) is similar to that of Eq. (11), see B.
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where I is identity matrix. If we denote H = (G∗−κI)T , it can be shown that H satisfies
the conditions (13) and (14) for the Q-matrix (see B). In other words, the Kolmogorov
forward equation Eq. (12) is a special linear case of the nonlinear proportion equation
Eq. (15). This relation implies that, when the division rates of the three phenotypes are
the same, the dynamics of the phenotypic proportion can equivalently be captured by the
Markov chain model where only the phenotypic transitions are accounted for. Otherwise,
the Markov chain model may oversimplify the phenotypic dynamics with unequal division
rates. Interestingly, it was reported in Gupta et al’s experiment that the subpopulations of
S, B and L phenotypes have the same “doubling time” [6], which justified their application
of the Markov chain model. However, as mentioned in the end of Sec. 3.1, Eq. (9)
is valid only in relatively short time scale. For larger time scales, it is unreasonable to
model the three-phenotypic dynamics by the Markov chain model taking no account of
different capabilities of divisions by cancer stem cells (unlimited) and non-stem cancer
cells (limited), even if they have the same division rate. Therefore, one should be cautious
about the application of the Markov chain in modeling cell-state dynamics.
3.4 Path-wise convergence of the MPB model
We have seen that the MPB model provides a unified framework for the ODEs model and
Markov chain model. In this section, we will show path-wise convergence of the MPB
model, which provides a much stronger concept of stability by which both the stable
steady-state behavior of the ODEs model and the equilibrium distribution of the Markov
chain model will serve as average-level stabilities of the MPB model.
Much attention has long been paid to the limit theorems of multi-type branching pro-
cesses by mathematicians [28, 29, 30, 31]. Here we are not going to discuss the rigorous
mathematical theory in general (which is the focus of our another work [22]). Instead we
are more interested in the specific results related to the phenotypic equilibrium, i.e. the
conditions under which ~p converges to a positive vector ~µ. Unlike the ~p in Theorem 1, the
~p here is stochastic. The “convergence” here means almost sure convergence. That is, if
the convergence of ~p holds, almost all the stochastic paths will tend to a fixed equilibrium
(also termed path-wise convergence).
We present our main results in the following two theorems (see D for the proofs and
mathematical details):
Theorem 2. If G in Eq. (7) is irreducible and its Perron-Frobenius eigenvalue is positive,
then ~p will tend to a fixed positive vector ~µ almost surely as t → ∞ conditioned on
non-extinction of the population.
Theorem 3. Assume that
(1) all the phenotypic transition rates are zero, i.e. βB, βL and γB, γL are zero;
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(2) αS > 0, αB > 0 and αL > 0;
(3) Pi > 0 (1 ≤ i ≤ 5) and P1 > P2 + P3;
then ~p will tend to a fixed positive vector ~µ almost surely as t → ∞ conditioned on
non-extinction of stem like cells.
The above two theorems are applicable to different cases. Theorem 2 corresponds
to the case with phenotypic plasticity, since the irreducibility of G is satisfied as long as
the conversions between different phenotypes can happen. In contrast, Theorem 3 corre-
sponds to the case without phenotypic plasticity, since all the phenotypic transition rates
are assumed to be zero. Interestingly, even though the assumptions of the two theorems
are basically different, both of them can lead to the path-wise convergence ~p. Further-
more, it is easy to see that the path-wise convergence of ~p∗ is implied by Theorems 2 and
3:
Corollary 2. ~p∗ will tend to a fixed positive vector ~µ∗ almost surely as t→∞ under the
conditions in either Theorem 2 or Theorem 3.
Figs. 2 and 3 illustrate the path-wise convergence of ~p∗ implied by Theorems 2 and 3
respectively by using stochastic simulations (E shows the simulations for ~p in details). In
both cases, even though all the stochastic paths fluctuate at the beginning of the process,
the proportions of S, B and L cells eventually converge to their equilibrium proportions
as time passes. Since the path-wise convergence indicates the stability of (almost) every
stochastic sample, the convergence of the mean dynamics just follows from it by aver-
aging all the stochastic samples (see lower panels of Figs. 2 and 3). Note that both the
Kolmogorov forward equation of the Markov chain and the ODEs model can be seen as
the mean dynamics of the phenotypic proportions; their stabilities just correspond to the
average-level stabilities of the MPB model, which can be seen as direct results of the
path-wise convergence. In this way, the path-wise convergence provides a deeper under-
standing to the phenotypic equilibrium from the stochastic point of view.
As the end of this section, it is noteworthy to emphasize that, according to Theorem 3,
the phenotypic equilibrium can still happen in the paradigm of conventional cancer stem
cell theory. The assumptions in Theorem 3 together indicate the cellular hierarchy pro-
posed by the cancer stem cell theory [24]. That is, cancer stem cells (S cells) are capable
of differentiation into other more committed non-stem cancer cells (B and L cells) but
not vice versa. In this way, cancer stem cells are at the apex of this cellular hierarchy.
Moreover, the assumption “P1 > P2 + P3” implies the dominance of S phenotype during
the growth of the population. To show this, note that αS (P1 − P2 − P3) is the eigenvalue
corresponding to S phenotype of G in Eq. (19), which is the only positive eigenvalue of
G provided “P1 > P2 + P3” (see D). In other words, instead of the phenotypic plastic-
ity, Theorem 3 also gives an alternative explanation to the phenotypic equilibrium in the
12
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Figure 2: Stochastic simulations for the case with phenotypic plasticity (Theorem 2).
Upper panel shows the stochastic path-wise dynamics of the phenotypic proportions of S
(blue), B (black) and L (red). The initial numbers of S, B and L cells are assumed to be 20,
0 and 0 respectively, that is, the initial proportions of S, B and L cells are 100%, 0% and
0%. According to the assumptions in Theorem 2, we set m = 10; αS = 0.8, P1 = 0.3,
P2 = 0.2, P3 = 0.2, P4 = 0.15, P5 = 0.15; αB = 0.6, αBm = 0.3, βB = 0.1, γB = 0.05;
αL = 0.7, αLm = 0.3, βL = 0.13, γL = 0.2. Thirty stochastic samples for each phenotype
were produced. It is shown that even though the stochastic paths fluctuate at the beginning
of the process, the proportions of S, B and L phenotypes eventually path-wisely tend to
their equilibrium proportions respectively. Lower panel shows the mean dynamics of the
phenotypic proportions by averaging all the thirty samples shown in upper panel.
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Figure 3: Stochastic simulations for the case without phenotypic plasticity (Theorem 3).
The initial cell numbers of S, B and L cells are also assumed to be 20, 0 and 0 respectively.
According to the assumptions in Theorem 3, we set m = 10; αS = 0.8, P1 = 0.5,
P2 = 0.14, P3 = 0.16, P4 = 0.1, P5 = 0.1; αB = 0.4, αBm = 0.3, βB = 0, γB = 0;
αL = 0.45, αLm = 0.3, βL = 0, γL = 0. Ten stochastic samples for each phenotype were
produced. Upper panel shows the path-wise convergence of the phenotypic proportions.
Lower panel shows the average-level stability of the mean dynamics.
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framework of the cancer stem cell theory, as long as the cancer stem cell phenotype is
dominant in the population. However, it is interesting to see that the convergence rate of
the case in Fig. 2 is faster than that of the case in Fig. 3, even though they both give
rise to the path-wise convergence. This suggests that perhaps the convergence rate (rather
than the convergence itself) could serve as an indicator to distinguish the models with
and without phenotypic plasticity, which might be another meaningful research topic in
future.
4 Conclusions
In this study, we have presented a multi-phenotype branching model of cancer cells. On
one hand, this model can serve as an underlying model from which the ODEs model
and the Markov chain model can be deduced. On the other hand, the almost sure con-
vergence of the model enhances our understanding of the phenotypic equilibrium, from
average-level stability to path-wise convergence. Furthermore, our results have indicated
that, even though the phenotypic plasticity facilitates the phenotypic equilibrium, it is not
indispensable in some cases. It has been shown that the conventional cancer stem cell
model can also stabilize the mixture of the phenotypic proportions, providing an alterna-
tive explanation to the phenotypic equilibrium.
Moreover, it should be noted that even though this work is focused on the issue of
cancer, our methods can conveniently be used to more generalized cell population dy-
namics [22]. To further reveal the biological mechanisms of the phenotypic equilibrium,
more detailed dynamic models of cancer cells are needed. For instance, the hypothesis of
cooperation among cancer cells has been put forward [32]. In particular, self-sufficiency
of certain growth signals of cancer cells supports the concept of mutualism and could
be an important mechanism supporting the phenotypic equilibrium. Therefore, the mod-
els of capturing the interactions among cancer cells, e.g. evolutionary game models [33],
could be a promising research direction in future. Furthermore, the genetic and epigenetic
state networks [34, 35] of cancer will enable us to explore the molecular mechanisms of
the phenotypic equilibrium, which are poorly understood. The network methods have
successfully been used to investigate the processes of cellular pluripotent reprogramming
[36] and epithelial-mesenchymal transitions (EMT) [37]. Note that EMT could play a key
role in regulating the phenotypic heterogeneity in cancer [38], further studies on it should
be another important tasks in future plans.
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A Expanded form of Eq. (2)
Here we show more details about the master equation Eq. (2)
dPr(~x; t)
dt
=
∑
~x′ 6=~x
T~x′→~xPr(~x′; t)−
∑
~x′ 6=~x
T~x→~x′Pr(~x; t).
To obtain the expanded form of Eq. (2), we need to confirm all possible T~x′→~x and
T~x′→~x. Based on the model assumptions, we can calculate T~x′→~x and T~x′→~x correspond-
ingly. For example, let ~x′ = (x1 − 1, x(0)2 , ..., x(m)2 , x(0)3 , ..., x(m)3 )T , the event “(x1 −
1, x
(0)
2 , ..., x
(m)
2 , x
(0)
3 , ..., x
(m)
3 )
T → (x1, x(0)2 , ..., x(m)2 , x(0)3 , ..., x(m)3 )T ” will happen if any
one of “S αSP1−→ S + S” happens. Since the number of S cells is x1 − 1 in current pop-
ulation, the transition rate should be (x1 − 1) × αSP1. On the other hand, the reaction
“S αSP1−→ S + S” can also lead to the transition from (x1, x(0)2 , ..., x(m)2 , x(0)3 , ..., x(m)3 )T →
(x1 + 1, x
(0)
2 , ..., x
(m)
2 , x
(0)
3 , ..., x
(m)
3 )
T with rate x1 × αSP1. Along this way we can deter-
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mine all the transition rates similarly. Therefore,∑
~x′ 6=~x
T~x′→~xPr(~x′; t) =
(x1 − 1)αSP1Pr(x1 − 1, x(0)2 , ..., x(m)2 , x(0)3 , ..., x(m)3 ; t)
+(x1 + 1)αSP2Pr(x1 + 1, x
(0)
2 − 2, ..., x(m)2 , x(0)3 , ..., x(m)3 ; t)
+(x1 + 1)αSP3Pr(x1 + 1, x
(0)
2 , ..., x
(m)
2 , x
(0)
3 − 2, ..., x(m)3 ; t)
+x1αSP4Pr(x1, x(0) − 1, ..., x(m)2 , x(0)3 , ..., x(m)3 ; t)
+x1αSP3Pr(x1, x
(0)
2 , ..., x
(m)
2 , x
(0)
3 − 1, ..., x(m)3 ; t)
+
m∑
i=1
(x
(i−1)
2 + 1)αBPr(x1, ..., x
(i−1)
2 + 1, x
(i)
2 − 2, ...; t)
+(x
(m)
2 + 1)αBmPr(x1, x
(0)
2 , ..., x
(m)
2 + 1, x
(0)
3 , ..., x
(m)
3 ; t)
+
m∑
i=0
(x
(i)
2 + 1)βBPr(x1 − 1, ..., x(i)2 + 1, ...; t)
+
m∑
i=0
(x
(i)
2 + 1)γBPr(x1, ..., x
(i)
2 + 1, ..., x
(i)
3 − 1, ...; t)
+
m∑
i=1
(x
(i−1)
3 + 1)αLPr(x1, ..., x
(i−1)
3 + 1, x
(i)
3 − 2, ...; t)
+(x
(m)
3 + 1)αLmPr(x1, x
(0)
2 , ..., x
(m)
2 , x
(0)
3 , ..., x
(m)
3 + 1; t)
+
m∑
i=0
(x
(i)
3 + 1)βLPr(x1 − 1, ..., x(i)3 + 1, ...; t)
+
m∑
i=0
(x
(i)
3 + 1)γLPr(x1, ..., x
(i)
2 − 1, ..., x(i)3 + 1, ...; t),
and ∑
~x′ 6=~x
T~x→~x′Pr(~x; t) = x1
5∑
i=1
αSPiPr(~x; t)
+
m−1∑
i=0
αBx
(i)
2 Pr(~x; t) + αBmx
(m)
2 Pr(~x; t) +
m∑
i=0
(βB + γB)x
(i)
2 Pr(~x; t)
+
m−1∑
i=0
αLx
(i)
3 Pr(~x; t) + αLmx
(m)
3 Pr(~x; t) +
m∑
i=0
(βL + γL)x
(i)
3 Pr(~x; t).
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B Proportion equation and Kolmogorov forward equa-
tion
Firstly we show how to derive the proportion equation (11) from the number equation (6).
Let us rewrite the matrix form of Eq. (6) into component form 3:
d〈Xi〉
dt
= gi1〈X1〉+ gi1〈X2〉+ ...+ gin〈Xn〉.
Note that
pi =
〈Xi〉
〈X1 +X2 + ...+Xn〉 =
〈Xi〉
N
,
d〈Xi〉
dt
=
d(piN)
dt
= pi
dN
dt
+N
dpi
dt
,
then
dpi
dt
=
1
N
d〈Xi〉
dt
− pi
N
dN
dt
=
n∑
j=1
(gijpj)− pi
n∑
k=1
n∑
j=1
(gkjpj).
When turning the above component form back to the matrix form, we get Eq. (11)
d~p
dt
= G~p− ~peTG~p.
Similarly, we can also get the proportion equation Eq. (8) for ~p∗
d~p∗
dt
= G∗~p∗ − ~p∗eTG∗~p∗. (17)
In what follows we show how the proportion equation Eq. (17) relates to the Kolmogorov
forward equation of continuous-time Markov chain. If the column sums of G∗ are the
same and equal to κ, i.e.
αS = αB = αL = κ,
then
d~p∗
dt
= G∗~p∗ − κ~p∗ = HT~p∗.
3The dimension of G is 2m+ 3, for simplicity we let 2m+ 3 = n.
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where H = (G∗ − κI)T and I is identity matrix. For any i 6= j, it is easy to see that
hij = g
∗
ji. Note that all the off-diagonal elements of G
∗ are non-negative, so hij ≥ 0,
satisfying the condition Eq. (13). Meanwhile, hii = g∗ii − κ. Note that κ =
∑
j g
∗
ji,
hii = g
∗
ii − κ = −
∑
j 6=i
g∗ji = −
∑
j 6=i
hij,
satisfying the condition Eq. (14). Hence H corresponds to the Q-matrix of a continuous-
time Markov chain.
C Proof of Theorem 1
First of all, we have two remarks on G in Eq. (7):
• Note that the off-diagonal elements of G are all non-negative, we call G an ML-
matrix (see Chapter 2 in [17]). For sufficiently large τ ,G+τI is a non-negative ma-
trix (I is an identity matrix). In other words, ML-matrix is essentially non-negative.
The ML-matrix G is said to be irreducible if G+ τI is irreducible 4.
• When G is irreducible, from Theorem 2.6 in [17], there exists a Perron-Frobenius
eigenvalue λ1 satisfying that 1) λ1 is real and λ1 > Reλ for any eigenvalue λ 6= λ1;
2) λ1 is simple, i.e. a simple root of the characteristic equation of G; 3) λ1 is
associated with (up to constant multiples) unique positive right eigenvector ~µ. Here
we assume that ~µ is the normalized right eigenvector of λ1, that is, µ1 + µ2 + ...+
µn = 1.
Since λ1 is simple, the solution of Eq. (6) can be expressed as
〈 ~X〉 = c1,1~µeλ1t +
m∑
j=2
mj∑
l=1
cj,l
mj∑
i=1
~rjl,it
i−1eλjt, (18)
where λ1, λ2, · · ·λm are the different eigenvalues of G, mj is the algebraic multiplicity of
λj ,
~rjl,i is the corresponding eigenvector of λj , cj,l is determined by initial states. Suppose
c1,1 6= 0, since Reλi < λ1 (i 6= 1),
lim
t→+∞
〈 ~X〉
c1,1eλ1t
= ~µ+ lim
t→+∞
m∑
j=2
mj∑
l=1
cj,l
c1,1
mj∑
i=1
~rjl,it
i−1e(λj−λ1)t = ~µ.
4A non-negative matrix M is said to be irreducible, if for every pair of indices i and j, there exists a
natural number k such that [Mk]ij is larger than 0.
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Thus
~p =
〈 ~X〉
〈X1 +X2 + ...+Xn〉 =
〈 ~X〉/c1,1eλ1t
〈X1 + ...+Xn〉/c1,1eλ1t →
~µ
µ1 + ...+ µn
= ~µ > 0.
Before completing the proof, we need to discuss the case c1,1 = 0. In this case, the
above argument does not work. However, since fluctuations are inevitable in real world,
c1,1 = 0 will hardly happen in reality. To show this, let t = 0 in Eq. (18)
c1,1~µ+
m∑
j=2
mj∑
l=1
cj,l
~rjl,1 = 〈 ~X0〉.
This is a linear equation of cj,l. By Cramer’s Rule we have
c1,1 =
det|B∗|
det|B| ,
where B = [~µ ~r21,1 ~r22,1 · · · ~rmmm,1], B∗ is just B with its first column replaced by 〈 ~X0〉. It
is easy to add a small perturbation ε~v to 〈 ~X0〉, so that all the columns of B∗ are linear
independent, hence c1,1 6= 0 holds.
D Proofs of Theorems 2 and 3
The proofs of Theorems 2 and 3 are both on the basis of the following lemma 5:
Lemma 1 (Theorem 5 in [22]). Assume that the Perron-Frobenius eigenvalue λ1 of G
in Eq. (7) is simple and positive. Conditioned on essential non-extinction, ~p will tend
to ~µ almost surely as t → ∞. ~µ is the normalized right eigenvector of λ1, which is
non-negative.
For proving Theorems 2 and 3, firstly we need to explain the concept of essential
non-extinction. We are not going to discuss the general mathematical definition of it (see
Sec. 4.2 in [22]). In our MPB model, essential non-extinction specifically means non-
extinction of the phenotype corresponding to the Perron-Frobenius eigenvalue λ1. For
Theorem 3, the assumptions (2) and (3) implies that the Perron-Frobenius eigenvalue of
G is g11 = αS(P1 − P2 − P3) (we will show this later). In other words, the essential
non-extinction here just means non-extinction of stem-like phenotype. For Theorem 2,
5As far as we know, Theorem 5 in [22] requires minimal constraint to the path-wise convergence of our
concern. However, it should be noted that technically our main results can also be proved based on Theorem
3.1 in [30].
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since G is irreducible, it is possible for any two phenotypes to (directly or indirectly)
inter-convert into each other. In this case, non-extinction of one particular phenotype is
equivalent to non-extinction of any phenotype. This implies that, no matter which phe-
notype corresponds to λ1, to guarantee essential non-extinction, it is sufficient to assume
non-extinction of the population in general. Therefore, the conditions provided in Theo-
rems 2 or 3 ensure the essential non-extinction of the model.
We now start to prove the two theorems. On one hand, we need to show that λ1
of G is simple and positive in both theorems. On the other hand, since Lemma 1 only
concludes the non-negativity of ~µ, we need to further show the positivity of ~µ. The proof
for Theorem 2 is straightforward, since we assume that G is irreducible, according to the
second remark in C, λ1 is simple and µ is positive. Note that λ1 is also assumed positive,
by Lemma 1 we have ~p→ ~µ > 0 almost surely as t→∞.
For Theorem 3, according to the assumptions, G reduces to a lower triangular matrix
as follows
G = [gij] =

αS(P1−P2−P3) 0 ··· ··· ··· ··· 0
αS(2P2+P4) −αB 0 ··· ··· ··· 0
0 2αB −αB 0 ··· ··· 0··· ··· ··· ··· ··· ··· ···
αS(2P3+P5) 0 −αL ··· 0
0 ··· ··· ··· 2αL −αL ······ ··· ··· ··· ··· ··· ···
 . (19)
It is easy to know that the eigenvalues of G correspond to the diagonal elements. By
assumptions (2) and (3), λ1 = αS (P1 − P2 − P3) is the Perron-Frobenious eigenvalue
which is positive and simple. By Lemma 1, we have ~p → ~µ almost surely as t → ∞,
where ~µ is the normalized right eigenvector of λ1. To complete the proof, we need to
show that ~µ is positive. Note that ~µ satisfies the following equation
G~µ = λ1~µ. (20)
By expanding this equation, we have
λ1µ1 = λ1µ1;
αS (2P2 + P4)µ1 = (αB + λ1)µ2;
2αBµ2 = (αB + λ1)µ3;
...
2αBµm = (αBm + λ1)µm+1;
αS (2P3 + P5)µ1 = (αL + λ1)µ(m+ 2);
2αLµm+2 = (αL + λ1)µm+3;
...
2αLµ2m+2 = (αLm + λ1)µ2m+3.
(21)
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Suppose µ1 > 0, then we have
µ2 =
αS (2P2 + P4)
αB + λ1
µ1 > 0
since αS (2P2 + P4) > 0 and αB + λ1 > 0. With the same logic, we can show the
positivity of µi recursively, which completes the final proof.
E Stochastic simulations for Theorems 2 and 3
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Figure 4: Illustration of Theorem 2. The parameters are the same as those in Fig. 2.
Dynamics of B and L phenotypes at each hierarchical level are shows in (a) and (b) re-
spectively.
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Figure 5: Illustration of Theorem 3. The parameters are the same as those in Fig. 3.
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